What is Mosie?
Mosie Baby operates at the intersection of health-tech and reproductive medicine, providing the first FDA-cleared at-home syringe insemination kit. By addressing the barriers to entry for couples facing conception challenges, the company has established a robust market position, serving over 100,000 families. Their product suite, which includes specialized syringes and collection cups, is engineered with clinical insights to offer a comfortable, non-judgmental, and effective alternative to traditional clinical artificial insemination procedures. This approach effectively bridges the gap between high-cost medical interventions and accessible, home-based care.
How much funding has Mosie raised?
Mosie has raised a total of $1M across 1 funding round:
Other Financing Round
$1M
Other Financing Round (2023): $1M with participation from MAGIC Fund
Key Investors in Mosie
MAGIC Fund
MAGIC Fund is an early-stage venture capital firm built by founders for founders, specializing in pre-seed and seed stage investments with a portfolio of over 250 startups.
What's next for Mosie?
With this latest round of financing, Mosie is well-positioned to scale its operations and expand its reach within the global fertility market. The strategic focus will likely center on enhancing product distribution channels, deepening research and development efforts to refine their existing kit, and potentially diversifying their portfolio of reproductive health tools. As the company transitions from its current growth phase into a more mature enterprise-level operation, the focus will remain on maintaining its reputation for clinical efficacy while navigating the complexities of the direct-to-consumer medical device landscape. The backing from key institutional partners provides the necessary runway to solidify their leadership in the at-home conception space.
See full Mosie company page
